Literature DB >> 28695434

The single-nucleotide polymorphism (SNP) of tumor necrosis factor α -308G/A gene is associated with early-onset primary knee osteoarthritis in an Egyptian female population.

Sahar M Abdel Galil1,2, Nillie Ezzeldin3, Faten Fawzy4, Mohamed El-Boshy5.   

Abstract

The objective of the present study is to investigate if there is a potential association between the single-nucleotide polymorphisms (SNPs) of the tumor necrosis factor alpha gene (TNF-α -308G/A, rs1800629) and the susceptibility to and severity of early-onset knee osteoarthritis in the Egyptian female population. Genotype distributions and allelic frequencies of TNF-α -308G/A polymorphism were investigated in 210 knee osteoarthritis (OA) patients and 210 age-, sex-, and ethnicity-matched healthy controls (HC). Polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP) amplifications were implemented to determine TNF-α -308G/A SNP. Serum and synovial fluid levels of TNF-α, besides ESR and CRP, as laboratory markers for inflammation, were estimated for all patients and HC. Plain X-ray as well as MRI knee was done for grading of OA. Disease severity was estimated by Western Ontario and McMaster University Osteoarthritis scores. Percentages of TNF-α-G308A genotypes GG, AG, and AA were 85.7, 11.9, and 2.4% in OA patients and 54.7, 39.1, and 6.2% in controls, respectively. The frequencies of the GG genotype and G allele were significantly higher in subjects with knee OA than in HC (P = 0.04 and P < 0.001, respectively). Logistic regression analysis showed that the GG genotype and G allele are independently associated with increased risk for knee OA (odds ratio = 3.13, 95% confidence interval = 1.04-9.39, P = 0.04 for GG genotype, and odds ratio = 3.81, 95% confidence interval = 2.52-5.76, P = 0.001 for G allele). There is a close relationship between TNF-α-G308A polymorphism and individual susceptibility to and severity of early-onset knee OA in the Egyptian females.

Entities:  

Keywords:  Egyptian females; Knee osteoarthritis; Single-nucleotide polymorphism; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 28695434     DOI: 10.1007/s10067-017-3727-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 2.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

3.  Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.

Authors:  M Rudwaleit; S Siegert; Z Yin; J Eick; A Thiel; A Radbruch; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

4.  Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index.

Authors:  E H Tüzün; L Eker; A Aytar; A Daşkapan; M Bayramoğlu
Journal:  Osteoarthritis Cartilage       Date:  2005-01       Impact factor: 6.576

5.  Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis.

Authors:  T Höhler; S Grossmann; B Stradmann-Bellinghausen; W Kaluza; E Reuss; K de Vlam; E Veys; E Märker-Hermann
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

6.  Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.

Authors:  Zahra Rezaieyazdi; Jalil Tavakol Afshari; Mahnaz Sandooghi; Farnaz Mohajer
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

7.  A genetic association study between growth differentiation factor 5 (GDF 5) polymorphism and knee osteoarthritis in Thai population.

Authors:  Tulyapruek Tawonsawatruk; Theeraroj Changthong; Sarinee Pingsuthiwong; Objoon Trachoo; Thanyachai Sura; Wiwat Wajanavisit
Journal:  J Orthop Surg Res       Date:  2011-09-21       Impact factor: 2.359

8.  Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk.

Authors:  Suotang Kou; Yaochi Wu
Journal:  BMC Musculoskelet Disord       Date:  2014-11-15       Impact factor: 2.362

9.  The effect of bradykinin B2 receptor polymorphisms on the susceptibility and severity of osteoarthritis in a Chinese cohort.

Authors:  Shuo Chen; Yong Zhou; Jun Li; Le-Qun Shan; Qing-Yu Fan
Journal:  J Biomed Biotechnol       Date:  2012-10-03

10.  Rs143383 in the growth differentiation factor 5 (GDF5) gene significantly associated with osteoarthritis (OA)-a comprehensive meta-analysis.

Authors:  Jie Liu; Wei Cai; Hongxin Zhang; Chuan He; Lianfu Deng
Journal:  Int J Med Sci       Date:  2013-02-05       Impact factor: 3.738

View more
  4 in total

1.  Association of TNF-α-308 G > A and -238G > A polymorphisms with knee osteoarthritis risk: A case-control study and meta-analysis.

Authors:  Mohammad Reza Sobhan; Masoud Mahdinezhad-Yazdi; Kazem Aghili; Masoud Zare-Shehneh; Shohreh Rastegar; Jalal Sadeghizadeh-Yazdi; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2018-05-09

2.  Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of osteoarthritis in a Chinese population.

Authors:  Jie Chen; Yu Wu; Jiannong Yu; Jinming Shen
Journal:  Braz J Med Biol Res       Date:  2018-05-28       Impact factor: 2.590

3.  Genetic association between TNF-α G-308A and osteoarthritis in Asians: A case-control study and meta-analysis.

Authors:  Chih-Chien Wang; Chih-Yun Huang; Meng-Chang Lee; Dung-Jang Tsai; Chia-Chun Wu; Sui-Lung Su
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

4.  Epigenetic modifications of tumor necrosis factor-alpha in joint cartilage tissue from osteoarthritis patients - CONSORT.

Authors:  Qiang Zhang; Zhengxiao Ouyang; Xiaoxia Song; Wei Zhu; Xinqiao Tang; Zhong Liu; Xiaoming Chen
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.